Showing results (61-70 of 184) with videos related to

Sort By:
Pageof 19
Transfusion|August 18, 2009
Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatmentRachael P Jackman, John W Heitman, Susanne Marschner, et al.
Transplantation|July 29, 2016
National Assessment of Hospitalization Rates for Incident End-Stage Renal Disease After Liver TransplantationNathan P Goodrich, Douglas E Schaubel, Abigail R Smith, et al.
Transfusion|June 7, 2005
Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technologyJunzhi Li, Owen Lockerbie, Dirk de Korte, et al.
Transfusion|January 11, 2013
Development of a riboflavin and ultraviolet light-based device to treat whole bloodHeather L Reddy, Suzann K Doane, Shawn D Keil, et al.
International Journal of Toxicology|December 6, 2012
Evaluation of the toxicity of intravenous delivery of auroshell particles (gold-silica nanoshells)Shayne C Gad, Kelly L Sharp, Charles Montgomery, et al.
Nature Communications|December 14, 2023
A computational toolbox for the assembly yield of complex and heterogeneous structuresAgnese I Curatolo, Ofer Kimchi, Carl P Goodrich, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 9, 2017
National assessment of early hospitalization after liver transplantation: Risk factors and association with patient survivalPratima Sharma, Nathan P Goodrich, Douglas E Schaubel, et al.
Statistics in Medicine|February 27, 2018
Estimating the effect of a rare time-dependent treatment on the recurrent event rateAbigail R Smith, Danting Zhu, Nathan P Goodrich, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 15, 2008
The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor qualityD E Schaubel, C S Sima, N P Goodrich, et al.
Transfusion|December 25, 2009
Evaluation of the Mirasol pathogen [corrected] reduction technology system against Babesia microti in apheresis platelets and plasmaLaura Tonnetti, Melanie C Proctor, Heather L Reddy, et al.
Pageof 19